Intravitreal Therapy for Uveitic Macular Edema-Ranibizumab versus Methotrexate versus the Dexamethasone Implant: The MERIT Trial Results.
- DOI
- 10.1016/j.ophtha.2023.04.011
- Published
- 2023 Sep
- Container
- Ophthalmology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ophtha.2023.04.011,
title = {Intravitreal Therapy for Uveitic Macular Edema-Ranibizumab versus Methotrexate versus the Dexamethasone Implant: The MERIT Trial Results.},
author = {Multicenter Uveitis Steroid Treatment Trial (MUST) Research Group, Writing Committee: and Acharya NR and Vitale AT and Sugar EA and Holbrook JT and Burke AE and Thorne JE and Altaweel MM and Kempen JH and Jabs DA},
year = {2023},
journal = {Ophthalmology},
doi = {10.1016/j.ophtha.2023.04.011},
url = {https://doi.org/10.1016/j.ophtha.2023.04.011}
}RIS
TY - JOUR TI - Intravitreal Therapy for Uveitic Macular Edema-Ranibizumab versus Methotrexate versus the Dexamethasone Implant: The MERIT Trial Results. AU - Multicenter Uveitis Steroid Treatment Trial (MUST) Research Group, Writing Committee: AU - Acharya NR AU - Vitale AT AU - Sugar EA AU - Holbrook JT AU - Burke AE AU - Thorne JE AU - Altaweel MM AU - Kempen JH AU - Jabs DA PY - 2023 JO - Ophthalmology DO - 10.1016/j.ophtha.2023.04.011 UR - https://doi.org/10.1016/j.ophtha.2023.04.011 ER -
APA
Committee:, M. U. S. T. T. (. R. G. W., NR, A., AT, V., EA, S., JT, H., AE, B., JE, T., MM, A., JH, K., & DA, J. (2023). Intravitreal Therapy for Uveitic Macular Edema-Ranibizumab versus Methotrexate versus the Dexamethasone Implant: The MERIT Trial Results.. Ophthalmology. https://doi.org/10.1016/j.ophtha.2023.04.011
Source records
- pubmed · retrieved 2026-09-27T09:28:23.585Z